Export this record

Export record to excel

File type to download

Beta version

Select record 2

ArticlesPeer ReviewedFull Text

Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial

Author / Creator:Sternberg, Cora N, Dr ; Skoneczna, Iwona, MD ; Kerst, J Martijn, PhD ; Albers, Peter, Prof ; Fossa, Sophie D, Prof ; Agerbaek, Mads, MD ; Dumez, Herlinde, Prof ; de Santis, Maria, MD ; Théodore, Christine, MD ; Leahy, Michael G ; Chester, John D, Prof ; Verbaeys, Antony, Prof ; Daugaard, Gedske, Prof ; Wood, Lori, MD ; Witjes, J Alfred, PhD ; de Wit, Ronald, Prof ; Geoffrois, Lionel, MD ; Sengelov, Lisa, DMSc ; Thalmann, George, Prof ; Charpentier, Danielle, MD ; Rolland, Frédéric, MD ; Mignot, Laurent, MD ; Sundar, Santhanam, MRCP ; Symonds, Paul, Prof ; Graham, John, FRCP ; Joly, Florence, Prof ; Marreaud, Sandrine, MD ; Collette, Laurence, PhD ; Sylvester, Richard, ScD

Publisher:England: Elsevier Ltd

Journal title:The lancet oncology, 2015-01, Vol.16 (1), p.76-86

View online as a Library member

Export record to excel

Export this record

Export record to excel

Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial

Export this record

Export record to excel

Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial

Refine your search